Unleashing the potential of catalytic RNAs to combat mis-spliced transcripts

Bashayer A. Khalifah,Shareefa A. Alghamdi,Ali H. Alhasan

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY(2023)

引用 0|浏览3
暂无评分
摘要
Human transcriptome can undergo RNA mis-splicing due to spliceopathies contributing to the increasing number of genetic diseases including muscular dystrophy (MD), Alzheimer disease (AD), Huntington disease (HD), myelodysplastic syndromes (MDS). Intron retention (IR) is a major inducer of spliceopathies where two or more introns remain in the final mature mRNA and account for many intronic expansion diseases. Potential removal of such introns for therapeutic purposes can be feasible when utilizing bioinformatics, catalytic RNAs, and nano-drug delivery systems. Overcoming delivery challenges of catalytic RNAs was discussed in this review as a future perspective highlighting the significance of utilizing synthetic biology in addition to high throughput deep sequencing and computational approaches for the treatment of mis-spliced transcripts.
更多
查看译文
关键词
intron retention,synthetic biology,spliceosome,spliceopathies,catalytic RNAs
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要